4885.T
MUROMACHI CHEMICALS INC.
スタンダード · 医薬品 · 医薬品 · JP
JPY 904.00
+0.22%Year over year
Reported trailing growth
- Revenue
- +10.6%
- EBITDA
- —
- EBIT
- +24.0%
- EPS
- -15.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.1%
- EBITDA
- —
- EPS
- +42.2%
Three-year CAGR
- Revenue
- +5.4%
- EBITDA
- +3.3%
- EBIT
- -0.4%
- Net income
- -19.1%
- EPS
- -21.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026